| Literature DB >> 27718769 |
Sabzar Ahmad Dar1, Abdul Rehman Yousuf1, Masood-Ul-Hassan Balkhi2, Bashir Ahmad Ganai3, Mudasir Tantry3, Farooz Ahmad Bhat2.
Abstract
CONTEXT: Medicinal plants continue to act as a repository for novel drug leads with novel mechanisms of action. Podophyllum hexandrum Royale (Berberideceae) treats diverse conditions in folk medicine.Entities:
Keywords: DPPH assay; GC-MS; Mutation; antimutagenicity; mayapple
Mesh:
Substances:
Year: 2016 PMID: 27718769 PMCID: PMC7011986 DOI: 10.1080/13880209.2016.1233568
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Frequency profile of CA induced by endosulfan and P. hexandrum extracts separately followed by their combination for different time intervals to evaluate the antimutagenicity in C. carassius.
| Classical aberrations | Non-classical aberrations | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Experiments | Treatment | TMS | Csb | Ctb | Frg | Scu | Dic | Mla | Stp | Cmt | Total aberrations,Mean (%) ± S.D. |
| 48 | Cont. 1 | 105 | 1 | 1 | – | – | – | – | 1 | – | 2.85 ± 0.212 |
| Cont. 2 | 102 | 1 | 1 | – | – | – | – | – | 1 | 2.94 ± 0.162 | |
| ES | 117 | 2 | 2 | 2 | – | 1 | – | 2 | – | 7.69 ± 0.37Bb | |
| HEPH | 114 | – | 1 | 1 | – | – | – | 1 | 1 | 3.50 ± 0.182 | |
| CEPH | 108 | 1 | 2 | – | – | – | – | – | 1 | 3.70 ± 0.232 | |
| EEPH | 111 | 1 | 1 | 1 | – | – | – | 1 | – | 3.60 ± 0.182 | |
| MEPH | 100 | 2 | 1 | – | – | – | – | – | – | 3.00 ± 0.222 | |
| AEPH | 115 | 1 | 1 | – | – | – | – | 1 | 1 | 3.47 ± 0.182 | |
| ES + HEPH | 110 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | – | 7.27 ± 0.29Bb | |
| ES + CEPH | 113 | 2 | 2 | 1 | – | 1 | 1 | 2 | – | 7.96 ± 0.35Bb | |
| ES + EEPH | 109 | 1 | 2 | 1 | – | – | – | 1 | 1 | 5.50 ± 0.26Bb2 | |
| ES + MEPH | 103 | 1 | 2 | 1 | – | – | – | 1 | – | 4.85 ± 0.25Bb2 | |
| ES + AEPH | 107 | 1 | 2 | 1 | 1 | 1 | – | 1 | – | 6.54 ± 0.28Bb | |
| 72 | Cont. 1 | 104 | 1 | 1 | – | – | – | – | 1 | – | 2.88 ± 0.162 |
| Cont. 2 | 101 | 1 | – | 1 | – | – | – | 1 | – | 2.97 ± 0.172 | |
| ES | 110 | 2 | 2 | 1 | 1 | 1 | – | 2 | 1 | 9.09 ± 0.37Bb | |
| HEPH | 116 | 1 | 1 | 1 | – | – | – | – | 1 | 3.44 ± 0.182 | |
| CEPH | 114 | 1 | 1 | 2 | – | – | – | – | – | 3.50 ± 0.222 | |
| EEPH | 113 | – | 1 | 2 | – | – | – | – | 1 | 3.53 ± 0.222 | |
| MEPH | 109 | 1 | 1 | 1 | – | – | – | 1 | – | 3.66 ± 0.182 | |
| AEPH | 100 | – | 1 | 1 | – | – | – | 1 | – | 3.00 ± 0.172 | |
| ES + HEPH | 106 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | – | 8.41 ± 0.33Bb | |
| ES + CEPH | 112 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | – | 8.92 ± 0.36Bb | |
| ES + EEPH | 117 | 1 | 2 | 2 | 1 | – | – | – | 1 | 5.98 ± 0.30Bb2 | |
| ES + MEPH | 115 | 2 | 1 | 1 | – | – | 1 | – | 1 | 5.21 ± 0.25Bb2 | |
| ES + AEPH | 111 | 1 | 1 | 2 | 2 | 1 | 2 | – | – | 8.10 ± 0.36Bb | |
| 96 | Cont. 1 | 119 | 2 | 1 | – | – | – | – | 1 | – | 3.36 ± 0.222 |
| Cont. 2 | 108 | – | – | 2 | – | – | – | 1 | 1 | 3.70 ± 0.232 | |
| ES | 107 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 12.14 ± 0.47B | |
| HEPH | 108 | 1 | 1 | 1 | – | – | – | – | 1 | 3.70 ± 0.182 | |
| CEPH | 102 | – | 1 | 2 | – | – | – | 1 | – | 3.92 ± 0.242 | |
| EEPH | 107 | 2 | 1 | – | – | – | – | – | 1 | 3.73 ± 0.232 | |
| MEPH | 105 | 1 | – | 1 | – | – | – | 1 | 1 | 3.80 ± 0.192 | |
| AEPH | 101 | 1 | 2 | 1 | – | – | – | – | – | 3.96 ± 0.242 | |
| ES + HEPH | 110 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 11.81 ± 0.44Bb | |
| ES + CEPH | 109 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 11.92 ± 0.44Bb | |
| ES + EEPH | 116 | 1 | 2 | 2 | 1 | 1 | 1 | – | – | 6.89 ± 0.31Bb2 | |
| ES + MEPH | 113 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | 6.19 ± 0.24Bb2 | |
| ES + AEPH | 104 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | – | 9.61 ± 0.38Bb2 | |
Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla; multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; ES: endosulfan; HEPH; CEPH; EEPH; MEPH and AEPH represent the hexane, chloroform, ethyl acetate, methanol and aqueous extract of P. hexandrum, respectively. Values with different upper and lower letter superscripts differ significantly (Aap < .05 = significant; Bbp < .01 = highly significant; Ccp < .001 = extremely significant) from the control 1 and 2, respectively (Newman–Keuls and Dunnett’s multiple comparison test), whereas values with different numeric superscripts differ significantly (1p < .05 = significant; 2p < .01 = highly significant; 3p < .001 = extremely significant) from the endosulfan group (Dunnett’s multiple comparison test).
Frequency profile of CA induced alone by endosulfan and in combination with the variable concentrations of the active extracts of P. hexandrum for different time intervals to evaluate the concentration-dependent antimutagenic response in C. carassius.
| Classical aberrations | Non-classical aberrations | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Exp. | Treatment | TMS | Csb | Ctb | Frg | Scu | Dic | Mla | Stp | Cmt | Total aberrationsMean (%)± S.D. |
| 48 | Cont. 1 | 105 | 1 | 1 | – | – | – | – | 1 | – | 2.85 ± 0.212 |
| Cont. 2 | 102 | 1 | 1 | – | – | – | – | – | 1 | 2.94 ± 0.162 | |
| Endosulfan | 117 | 2 | 2 | 1 | 1 | 1 | – | 2 | – | 7.69 ± 0.37Bb | |
| EE-T1 | 111 | 2 | 1 | 2 | 1 | – | – | – | 1 | 6.30 ± 0.30Bb | |
| EE-T2 | 104 | 1 | 2 | 1 | 1 | 1 | – | – | – | 5.76 ± 0.27Bb2 | |
| EE-T3 | 109 | 1 | 2 | 1 | – | – | – | 1 | 1 | 5.50 ± 0.26Bb2 | |
| ME-T1 | 110 | – | 1 | 2 | 1 | 1 | 1 | – | – | 5.55 ± 0.26Bb2 | |
| ME-T2 | 108 | 1 | 1 | 1 | – | – | 1 | – | 1 | 4.62 ± 0.21Aa2 | |
| ME-T3 | 103 | 1 | 2 | 1 | – | – | – | 1 | – | 4.85 ± 0.25Bb2 | |
| 72 | Cont. 1 | 104 | 1 | 1 | – | – | – | – | 1 | – | 2.88 ± 0.162 |
| Cont. 2 | 101 | 1 | – | 1 | – | – | – | 1 | – | 2.97 ± 0.172 | |
| Endosulfan | 110 | 2 | 2 | 1 | 1 | 1 | – | 2 | 1 | 9.09 ± 0.37Bb | |
| EE-T1 | 116 | 1 | 2 | 1 | 1 | 1 | 2 | – | – | 6.89 ± 0.31Bb2 | |
| EE-T2 | 111 | 1 | 1 | 1 | 1 | 1 | 2 | – | – | 6.30 ± 0.27Bb2 | |
| EE-T3 | 112 | 1 | 2 | 2 | 1 | – | – | – | 1 | 5.98 ± 0.30Bb2 | |
| ME-T1 | 113 | 1 | 2 | 1 | 1 | 1 | 1 | – | – | 6.21 ± 0.27Bb2 | |
| ME-T2 | 119 | 2 | 1 | 1 | 1 | 1 | – | – | – | 5.04 ± 0.25Ba2 | |
| ME-T3 | 115 | 2 | 1 | 1 | – | – | 1 | – | 1 | 5.21 ± 0.25Bb2 | |
| 96 | Cont. 1 | 119 | 2 | 1 | – | – | – | – | 1 | – | 3.36 ± 0.222 |
| Cont. 2 | 108 | – | – | 2 | – | – | – | 1 | 1 | 3.70 ± 0.232 | |
| Endosulfan | 107 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 12.14 ± 0.47Bb | |
| EE-T1 | 117 | 2 | 2 | 2 | 1 | 1 | 2 | – | – | 8.54 ± 0.38Bb2 | |
| EE-T2 | 101 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | – | 7.92 ± 0.30Bb2 | |
| EE-T3 | 116 | 1 | 2 | 2 | 1 | 1 | 1 | – | – | 6.89 ± 0.31Bb2 | |
| ME-T1 | 107 | 1 | 1 | 2 | 1 | 1 | 2 | – | – | 7.47 ± 0.32Bb2 | |
| ME-T2 | 118 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | 5.93 ± 0.23Bb2 | |
| ME-T3 | 113 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | 6.19 ± 0.24Bb2 | |
Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla: multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-T1: ethyl acetate extract-treatment 1(0.05 mg/L endosulfan +5 mg/L EE); EE-T2: ethyl acetate extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L EE); EE-T3: ethyl acetate extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L EE); ME-T1: methanol extract treatment 1(0.05 mg/L endosulfan +5 mg/L ME); ME-T2: methanol extract treatment 2 (0.05 mg/L endosulfan +10 mg/L ME); ME-T3: methanol extract treatment 3 (0.05 mg/L endosulfan +15 mg/L ME).
Frequency profile of CA induced by endosulfan alone and in combination with column eluted fractions of active P. hexandrum extracts for different time intervals to evaluate the antimutagenicity in C. carassius.
| Classical aberrations | Non-classical aberrations | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Exp. | Treatment | TMS | Csb | Ctb | Frg | Scu | Dic | Mla | Stp | Cmt | Total aberrations mean (%)± S.D. |
| 48 | Cont. 1 | 105 | 1 | 1 | – | – | – | – | 1 | – | 2.85 ± 0.212 |
| Cont. 2 | 102 | 1 | 1 | – | – | – | – | – | 1 | 2.94 ± 0.162 | |
| Endosulfan | 117 | 2 | 2 | 1 | 1 | 1 | – | 2 | – | 7.69 ± 0.37Bb | |
| EE-F1 | 103 | 1 | 1 | – | 1 | 1 | 2 | – | – | 5.82 ± 0.27Bb2 | |
| EE-F2 | 106 | 1 | 1 | – | 1 | 1 | 1 | – | 1 | 5.66 ± 0.23Bb2 | |
| EE-F3 | 113 | 1 | 1 | 2 | 1 | 1 | – | – | – | 5.30 ± 0.26Bb2 | |
| EE-F4 | 101 | 1 | – | 1 | – | – | 1 | 1 | 1 | 4.95 ± 0.21Bb2 | |
| EE-F5 | 107 | 1 | 2 | 1 | 1 | 1 | – | – | – | 5.60 ± 0.26Bb2 | |
| ME-F1 | 116 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | 5.17 ± 0.22Bb2 | |
| ME-F2 | 118 | 1 | 1 | 2 | – | – | 1 | – | – | 4.23 ± 0.242 | |
| ME-F3 | 113 | 2 | 1 | 1 | – | – | 1 | – | – | 4.42 ± 0.24A2 | |
| ME-F4 | 114 | 1 | – | 1 | 1 | 1 | – | 1 | 1 | 5.26 ± 0.22Bb2 | |
| ME-F5 | 115 | 1 | 2 | 2 | 1 | 1 | – | – | – | 6.08 ± 0.30Bb1 | |
| 72 | Cont. 1 | 104 | 1 | 1 | – | – | – | – | 1 | – | 2.88 ± 0.162 |
| Cont. 2 | 101 | 1 | – | 1 | – | – | – | 1 | – | 2.97 ± 0.172 | |
| Endosulfan | 110 | 2 | 2 | 1 | 1 | 1 | – | 2 | 1 | 9.09 ± 0.37Bb | |
| EE-F1 | 120 | 1 | 1 | 1 | 2 | 2 | – | 1 | – | 6.66 ± 0.31Bb2 | |
| EE-F2 | 100 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | 6.00 ± 0.23Bb2 | |
| EE-F3 | 119 | 2 | 1 | 2 | – | – | 1 | 1 | – | 5.88 ± 0.29Bb2 | |
| EE-F4 | 102 | 1 | – | 1 | – | – | 1 | 1 | 1 | 4.90 ± 0.21Bb2 | |
| EE-F5 | 108 | – | 1 | 2 | – | – | 2 | 1 | 1 | 6.48 ± 0.31Bb2 | |
| ME-F1 | 120 | 1 | 1 | 2 | – | – | 2 | 1 | – | 5.83 ± 0.29Bb2 | |
| ME-F2 | 114 | 1 | 1 | 1 | – | – | 1 | – | 1 | 4.38 ± 0.202 | |
| ME-F3 | 107 | 2 | 1 | 1 | 1 | 1 | – | – | – | 5.60 ± 0.26Bb2 | |
| ME-F4 | 109 | 1 | 1 | 1 | – | – | 1 | 1 | 1 | 5.50 ± 0.22Bb2 | |
| ME-F5 | 103 | 1 | 2 | 1 | 1 | 1 | 1 | – | – | 6.79 ± 0.28Bb2 | |
| 96 | Cont. 1 | 119 | 2 | 1 | – | – | – | – | 1 | – | 3.36 ± 0.222 |
| Cont. 2 | 108 | – | – | 2 | – | – | – | 1 | 1 | 3.70 ± 0.232 | |
| Endosulfan | 107 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 12.14 ± 0.47Bb | |
| EE-F1 | 109 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 8.25 ± 0.33Bb2 | |
| EE-F2 | 111 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | – | 7.20 ± 0.29Bb2 | |
| EE-F3 | 112 | 1 | 1 | 1 | 2 | 2 | 1 | – | – | 7.14 ± 0.32Bb2 | |
| EE-F4 | 105 | 1 | 1 | 2 | – | – | 1 | 1 | – | 5.71 ± 0.27Bb2 | |
| EE-F5 | 106 | 1 | 2 | 1 | 1 | 1 | – | 1 | 1 | 7.54 ± 0.29Bb2 | |
| ME-F1 | 113 | – | 2 | 3 | – | – | 2 | – | 1 | 7.07 ± 0.39Bb2 | |
| ME-F2 | 103 | – | 1 | 2 | – | – | 1 | 1 | – | 4.85 ± 0.252 | |
| ME-F3 | 104 | 2 | 1 | 1 | – | – | 1 | 1 | 1 | 6.73 ± 0.28Bb2 | |
| ME-F4 | 108 | 2 | 2 | 1 | – | – | 2 | – | 1 | 7.40 ± 0.35Bb2 | |
| ME-F5 | 116 | 1 | 2 | 1 | 2 | 2 | – | 1 | – | 7.75 ± 0.35Bb2 | |
Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla: multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-F1,2,3,4, and 5 designate the ethyl acetate extract fractions 1,2,3,4, and 5 (15 mg/L each), respectively, ME-F1,2,3,4, and 5 represent the methanol extract fractions 1,2,3,4, and 5 (10 mg/L), respectively.
Frequency profiles of micronuclei induced alone by endosulfan and P. hexandrum extracts followed by their simultaneous exposure for different time intervals to evaluate antimutagenicity in C. carassius.
| Number of MN | |||||||
|---|---|---|---|---|---|---|---|
| Exp. | Treatment | Total cells scored | 1 | 2 | 3 | Total no. of MN | Frequency of MN mean (%)± SD |
| 48 | Cont. 1 | 11,800 | 28 | – | – | 28 | 0.23 ± 0.132 |
| Cont. 2 | 11,320 | 28 | 1 | – | 30 | 0.26 ± 0.132 | |
| ES | 12,000 | 321 | 21 | 6 | 381 | 3.17 ± 0.83Bb | |
| HEPH | 11,490 | 30 | 3 | – | 36 | 0.31 ± 0.142 | |
| CEPH | 11,730 | 34 | 4 | – | 42 | 0.35 ± 0.152 | |
| EEPH | 11,980 | 31 | 1 | – | 33 | 0.27 ± 0.142 | |
| MEPH | 11,670 | 31 | – | – | 31 | 0.26 ± 0.152 | |
| AEPH | 11,560 | 33 | 1 | – | 35 | 0.30 ± 0.162 | |
| ES + HEPH | 11,330 | 334 | 13 | 5 | 375 | 3.30 ± 0.92Bb | |
| ES + CEPH | 11,840 | 329 | 15 | 6 | 377 | 3.18 ± 0.87Bb | |
| ES + EEPH | 11,648 | 177 | 11 | 2 | 205 | 1.75 ± 0.47Bb2 | |
| ES + MEPH | 11,594 | 135 | 9 | 2 | 159 | 1.37 ± 0.36Aa2 | |
| ES + AEPH | 11,210 | 321 | 8 | 1 | 340 | 3.03 ± 0.90Bb | |
| 72 | Cont. 1 | 11,550 | 23 | – | – | 23 | 0.19 ± 0.212 |
| Cont. 2 | 11,000 | 30 | – | – | 30 | 0.27 ± 0.112 | |
| Endosulfan | 11,250 | 320 | 35 | 4 | 402 | 3.57 ± 0.89Bb | |
| HEPH | 11,990 | 37 | 3 | – | 43 | 0.35 ± 0.172 | |
| CEPH | 11,100 | 38 | 5 | – | 48 | 0.43 ± 0.182 | |
| EEPH | 11,388 | 35 | 1 | – | 37 | 0.32 ± 0.172 | |
| MEPH | 11,715 | 37 | 1 | – | 39 | 0.33 ± 0.172 | |
| AEPH | 11,845 | 34 | – | – | 34 | 0.29 ± 0.162 | |
| ES + HEPH | 11,465 | 337 | 17 | 8 | 395 | 3.44 ± 0.92Bb | |
| ES + CEPH | 11,635 | 331 | 23 | 11 | 410 | 3.52 ± 0.89Bb | |
| ES + EEPH | 11,585 | 145 | 10 | 2 | 171 | 1.47 ± 0.39Ba2 | |
| ES + MEPH | 11,560 | 120 | 16 | 4 | 164 | 1.41 ± 0.32Ba2 | |
| ES + AEPH | 12,000 | 271 | 15 | 8 | 325 | 2.70 ± 0.70Bb | |
| 96 | Cont. 1 | 11,980 | 34 | 1 | – | 36 | 0.30 ± 0.162 |
| Cont. 2 | 11,220 | 36 | 1 | – | 38 | 0.33 ± 0.182 | |
| Endosulfan | 11,760 | 413 | 116 | 23 | 714 | 6.07 ± 1.11Bb | |
| HEPH | 11,068 | 34 | 5 | – | 44 | 0.39 ± 0.152 | |
| CEPH | 11,609 | 41 | 3 | – | 47 | 0.40 ± 0.192 | |
| EEPH | 11,872 | 38 | 1 | – | 40 | 0.33 ± 0.182 | |
| MEPH | 11,039 | 45 | – | – | 45 | 0.40 ± 0.232 | |
| AEPH | 11,317 | 45 | 2 | – | 49 | 0.43 ± 0.222 | |
| ES + HEPH | 11,000 | 421 | 89 | 27 | 680 | 6.18 ± 1.20Bb | |
| ES + CEPH | 11,427 | 440 | 99 | 19 | 695 | 6.08 ± 1.22Bb | |
| ES + EEPH | 11,005 | 178 | 46 | 15 | 315 | 2.86 ± 0.52Bb2 | |
| ES + MEPH | 11,740 | 197 | 33 | 9 | 290 | 2.47 ± 0.52Bb2 | |
| ES + AEPH | 12,000 | 386 | 68 | 21 | 585 | 4.87 ± 1.01Bb1 | |
Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; ES: endosulfan (0.05 mg/L); HEPH, CEPH, EEPH, MEPH and AEPH represent the hexane, chloroform, ethyl acetate, methanol and aqueous extract (15 mg/L each) of P. hexandrum, respectively.
Frequency profiles of micronuclei induced alone by endosulfan and in combination with the variable concentrations of the active extracts of P. hexandrum for different time intervals to evaluate the concentration-dependent antimutagenic response in C. carassius.
| Number of MN | |||||||
|---|---|---|---|---|---|---|---|
| Exp. | Treatment | Total cells scored | 1 | 2 | 3 | Total no. of MN | Frequency of MN mean (%)± SD |
| 48 | Cont. 1 | 11,800 | 28 | – | – | 28 | 0.23 ± 0.132 |
| Cont. 2 | 11,320 | 28 | 1 | – | 30 | 0.26 ± 0.132 | |
| Endosulfan | 12,000 | 321 | 21 | 6 | 381 | 3.17 ± 0.83Bb | |
| EE-T1 | 11,905 | 203 | 11 | 2 | 231 | 1.94 ± 0.53Bb | |
| EE-T2 | 11,730 | 192 | 8 | 3 | 217 | 1.84 ± 0.51Bb1 | |
| EE-T3 | 11,648 | 177 | 11 | 2 | 205 | 1.75 ± 0.47Aa1 | |
| ME-T1 | 11,560 | 118 | 23 | 7 | 185 | 1.60 ± 0.31Aa2 | |
| ME-T2 | 11,670 | 109 | 17 | 4 | 155 | 1.32 ± 0.292 | |
| ME-T3 | 11,594 | 135 | 9 | 2 | 159 | 1.37 ± 0.362 | |
| 72 | Cont. 1 | 11,550 | 23 | – | – | 23 | 0.19 ± 0.212 |
| Cont. 2 | 11,000 | 30 | – | – | 30 | 0.27 ± 0.112 | |
| Endosulfan | 11,250 | 320 | 35 | 4 | 402 | 3.57 ± 0.89Bb | |
| EE-T1 | 11,490 | 200 | 11 | 7 | 243 | 2.11 ± 0.96Bb1 | |
| EE-T2 | 11,730 | 121 | 29 | 5 | 194 | 1.65 ± 0.52Aa2 | |
| EE-T3 | 11,585 | 145 | 10 | 2 | 171 | 1.47 ± 0.69A2 | |
| ME-T1 | 11,670 | 144 | 19 | 3 | 191 | 1.63 ± 0.66Aa2 | |
| ME-T2 | 11,160 | 109 | 12 | 2 | 139 | 1.24 ± 0.522 | |
| ME-T3 | 11,560 | 120 | 16 | 4 | 164 | 1.41 ± 0.552 | |
| 96 | Cont. 1 | 11,980 | 34 | 1 | – | 36 | 0.30 ± 0.162 |
| Cont. 2 | 11,220 | 36 | 1 | – | 38 | 0.33 ± 0.182 | |
| Endosulfan | 11,760 | 413 | 116 | 23 | 714 | 6.07 ± 1.11Bb | |
| EE-T1 | 11,490 | 163 | 77 | 16 | 365 | 3.17 ± 0.64Bb2 | |
| EE-T2 | 11,730 | 126 | 91 | 26 | 386 | 3.29 ± 0.43Bb2 | |
| EE-T3 | 11,005 | 183 | 51 | 10 | 315 | 2.86 ± 0.80Bb2 | |
| ME-T1 | 11,670 | 127 | 61 | 21 | 312 | 2.67 ± 0.45Bb2 | |
| ME-T2 | 11,560 | 123 | 49 | 17 | 272 | 2.35 ± 0.47Bb2 | |
| ME-T3 | 11,740 | 197 | 33 | 9 | 290 | 2.47 ± 0.87Bb2 | |
Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-T1: ethyl acetate extract-treatment 1(0.05 mg/L endosulfan +5 mg/L EE); EE-T2: ethyl acetate extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L EE); EE-T3: ethyl acetate extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L EE); ME-T1: methanol extract-treatment 1(0.05 mg/L endosulfan +5 mg/L ME); ME-T2: methanol extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L ME); ME-T3: methanol extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L ME).
Frequency profiles of micronuclei induced by endosulfan alone and in combination with column eluted fractions of active P. hexandrum extracts for different time intervals to evaluate the antimutagenicity in C. carassius.
| Number of MN | |||||||
|---|---|---|---|---|---|---|---|
| Exp. | Treatment | Total cells scored | 1 | 2 | 3 | Total no. of MN | Frequency of MN mean (%)± SD |
| 48 | Cont. 1 | 11,800 | 28 | – | – | 28 | 0.23 ± 0.132 |
| Cont. 2 | 11,320 | 28 | 1 | – | 30 | 0.26 ± 0.132 | |
| Endosulfan | 12,000 | 321 | 21 | 6 | 381 | 3.17 ± 0.83Bb | |
| EE-F1 | 11,209 | 181 | 7 | 3 | 204 | 1.81 ± 0.90Aa1 | |
| EE-F2 | 11,200 | 136 | 13 | 5 | 177 | 1.58 ± 0.65Aa2 | |
| EE-F3 | 11,977 | 140 | 11 | 4 | 174 | 1.45 ± 0.632 | |
| EE-F4 | 11,743 | 138 | 8 | 2 | 160 | 1.36 ± 0.652 | |
| EE-F5 | 11,037 | 184 | 11 | 4 | 218 | 1.97 ± 0.92Bb | |
| ME-F1 | 11,410 | 113 | 25 | 6 | 181 | 1.58 ± 0.50Aa2 | |
| ME-F2 | 11,080 | 90 | 6 | 3 | 111 | 1.00 ± 0.442 | |
| ME-F3 | 11,635 | 112 | 9 | 3 | 139 | 1.19 ± 0.522 | |
| ME-F4 | 11,094 | 133 | 15 | 9 | 190 | 1.71 ± 0.62Aa1 | |
| ME-F5 | 11,595 | 229 | 18 | 5 | 280 | 2.41 ± 1.08Bb | |
| 72 | Cont. 1 | 11,550 | 23 | – | – | 23 | 0.19 ± 0.212 |
| Cont. 2 | 11,000 | 30 | – | – | 30 | 0.27 ± 0.112 | |
| Endosulfan | 11,250 | 320 | 35 | 4 | 402 | 3.57 ± 0.89Bb | |
| EE-F1 | 11,715 | 181 | 27 | 6 | 253 | 2.15 ± 0.81Bb1 | |
| EE-F2 | 11,940 | 159 | 23 | 4 | 217 | 1.81 ± 0.70Ba2 | |
| EE-F3 | 11,107 | 138 | 19 | 4 | 188 | 1.69 ± 0.66Aa2 | |
| EE-F4 | 11,333 | 101 | 14 | 3 | 138 | 1.21 ± 0.472 | |
| EE-F5 | 12,000 | 168 | 31 | 7 | 251 | 2.09 ± 0.72Bb1 | |
| ME-F1 | 11,820 | 172 | 12 | 3 | 205 | 1.73 ± 0.80Aa2 | |
| ME-F2 | 11,440 | 83 | 6 | 1 | 98 | 0.85 ± 0.402 | |
| ME-F3 | 11,255 | 128 | 11 | 2 | 156 | 1.38 ± 0.622 | |
| ME-F4 | 11060 | 132 | 30 | 5 | 207 | 1.87 ± 0.60Bb2 | |
| ME-F5 | 11,677 | 214 | 29 | 8 | 296 | 2.53 ± 0.97Bb | |
| 96 | Cont. 1 | 11,980 | 34 | 1 | – | 36 | 0.30 ± 0.162 |
| Cont. 2 | 11,220 | 36 | 1 | – | 38 | 0.33 ± 0.182 | |
| Endosulfan | 11,760 | 413 | 116 | 23 | 714 | 6.07 ± 1.11Bb | |
| EE-F1 | 11,300 | 197 | 101 | 18 | 453 | 4.00 ± 0.79Bb2 | |
| EE-F2 | 11,785 | 176 | 76 | 14 | 370 | 3.13 ± 0.69Bb2 | |
| EE-F3 | 11,950 | 169 | 71 | 11 | 344 | 2.87 ± 0.66Bb2 | |
| EE-F4 | 11,563 | 133 | 35 | 6 | 221 | 1.91 ± 0.57Aa2 | |
| EE-F5 | 11,110 | 166 | 79 | 16 | 372 | 3.34 ± 0.70Bb2 | |
| ME-F1 | 11,270 | 155 | 65 | 10 | 315 | 2.79 ± 0.64Bb2 | |
| ME-F2 | 11,830 | 121 | 7 | 3 | 144 | 1.21 ± 0.562 | |
| ME-F3 | 11,615 | 185 | 53 | 8 | 315 | 2.71 ± 0.79Bb2 | |
| ME-F4 | 11,404 | 183 | 56 | 9 | 322 | 2.82 ± 0.78Bb2 | |
| ME-F5 | 11,909 | 216 | 98 | 17 | 463 | 3.88 ± 0.84Bb2 | |
Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-F1,2,3,4 and 5 designate the ethyl acetate extract fraction 1,2,3,4, and 5 (15 mg/L each), respectively; ME-F1,2,3,4, and 5 represent the methanol extract fraction 1,2,3,4, and 5 (10 mg/L), respectively.
Figure 1.Antioxidant activity of active fractions of P. hexandrum expressed as rutin equivalents by the DPPH method.
Figure 2.TIC chromatogram of the methanol (ME-F2) and ethyl acetate (EE-F4) fraction of P. hexandrum. Peaks (A) 1: 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one; 2: 2-furancarboxaldehyde, 5-(hydroxymethyl); 3: hexadecanoic acid, methyl ester. (B) 1: n-hexadecanoic acid; 2: (3β)-stigmast-5-en-3-ol; 3: (3β)-stigmasta-5,22-dien-3-ol acetate; 4: deoxy-podophyllotoxin; 5: podophyllotoxin; 6: epiisopodophyllotoxin-acetate; X: minor fractions (detailed in results).